Nosocomial pneumonia: State of the science

被引:58
作者
Flanders, SA
Collard, HR
Saint, S
机构
[1] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO USA
[4] Dept Vet Affairs Hlth Serv, Res & Dev Ctr Excellence, Ann Arbor, MI USA
基金
美国医疗保健研究与质量局;
关键词
D O I
10.1016/j.ajic.2005.07.003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Nosocomial pneumonia is the leading cause of mortality due to hospital-acquired infections. A thorough understanding of the most recent developments in evaluating and managing nosocomial pneumonia is critical for infection control professionals and hospital epidemiologists, given the incidence and cost of this important patient safety problem. We review the evidence on pathogenesis, diagnosis, treatment, and prevention of both ventilator-associated and nonventilator-associated pneumonia. Key recommendations are then provided for diagnostic testing strategies, antibiotic selection, and treatment duration. We also summarize the most recent data on how to prevent hospital-acquired infection, in general, and nosocomial pneumonia, in particular.
引用
收藏
页码:84 / 93
页数:10
相关论文
共 88 条
[71]   Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals (Reprinted from Infection Control and Hospital Epidemiology, vol 18, pg 275-91, 1997) [J].
Shlaes, DM ;
Gerding, DN ;
John, JF ;
Craig, WA ;
Bornstein, DL ;
Duncan, RA ;
Eckman, MR ;
Farrer, WE ;
Greene, WH ;
Lorian, V ;
Levy, S ;
McGowan, JE ;
Paul, SM ;
Ruskin, J ;
Tenover, FC ;
Watanakunakorn, C .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :584-599
[72]   Linezolid for treatment of ventilator-associated pneumonia: A cost-effective alternative to vancomycin [J].
Shorr, AF ;
Susla, GM ;
Kollef, MH .
CRITICAL CARE MEDICINE, 2004, 32 (01) :137-143
[73]   Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia - Potential economic implications [J].
Shorr, AF ;
O'Malley, PG .
CHEST, 2001, 119 (01) :228-235
[74]   Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial [J].
Silvestri, L ;
van Saene, HKF ;
Milanese, M ;
Fontana, F ;
Gregori, D ;
Oblach, L ;
Piacente, N ;
Blazic, M .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :921-926
[75]   Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit - A proposed solution for indiscriminate antibiotic prescription [J].
Singh, N ;
Rogers, P ;
Atwood, CW ;
Wagener, MM ;
Yu, VL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :505-511
[76]   Multicenter study of hospital-acquired pneumonia in non-ICU patients [J].
Sopena, N ;
Sabrià, M .
CHEST, 2005, 127 (01) :213-219
[77]   Geriatric oral health and pneumonia risk [J].
Terpenning, M .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (12) :1807-1810
[78]   INCIDENCE, RISK, AND PROGNOSIS FACTORS OF NOSOCOMIAL PNEUMONIA IN MECHANICALLY VENTILATED PATIENTS [J].
TORRES, A ;
AZNAR, R ;
GATELL, JM ;
JIMENEZ, P ;
GONZALEZ, J ;
FERRER, A ;
CELIS, R ;
RODRIGUEZROISIN, R .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (03) :523-528
[79]   PULMONARY ASPIRATION OF GASTRIC CONTENTS IN PATIENTS RECEIVING MECHANICAL VENTILATION - THE EFFECT OF BODY POSITION [J].
TORRES, A ;
SERRABATLLES, J ;
ROS, E ;
PIERA, C ;
DELABELLACASA, JP ;
COBOS, A ;
LOMENA, F ;
RODRIGUEZROISIN, R .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (07) :540-543
[80]   Ventilator-associated pneumonia caused by potentially drug-resistant bacteria [J].
Trouillet, JL ;
Chastre, J ;
Vuagnat, A ;
Joly-Guillou, ML ;
Combaux, D ;
Dombret, MC ;
Gibert, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (02) :531-539